| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |